The Nondystrophic Myotonias

Neurotherapeutics

Volumn 4, Issue 2, 2007, Pages 238-251

  Heatwole, Chad R ^a   Moxley III, Richard T ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Becker's disease; hyperkalemic periodic paralysis with myotonia; myotonia levior; Nondystrophic myotonia; paramyotonia congenita; Thomsen's disease

Indexed keywords

ACETAZOLAMIDE; CARBAMAZEPINE; CHLORIDE CHANNEL; DANTROLENE; DICLOFENAMIDE; FLECAINIDE; GLUCOSE; HYDROCHLOROTHIAZIDE; LITHIUM; LITHIUM CARBONATE; MEXILETINE; PHENYTOIN; PROCAINAMIDE; QUININE; SALBUTAMOL; SODIUM CHANNEL; THIAZIDE DIURETIC AGENT; TOCAINIDE;

AGRANULOCYTOSIS; ALTERED TASTE; ANOREXIA; ARTICLE; BECKER MUSCULAR DYSTROPHY; CHANNELOPATHY; CLINICAL FEATURE; CONFUSION; DEATH; DEPRESSION; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DROWSINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDICATION; DRUG RESPONSE; DRUG SAFETY; DYSPEPSIA; EXERCISE TEST; GENE MUTATION; HUMAN; HYPERKALEMIC PERIODIC PARALYSIS WITH MYOTONIA; INTERSTITIAL LUNG DISEASE; LIVER DYSFUNCTION; MENTAL INSTABILITY; MYOTONIA; NAUSEA; NEPHROLITHIASIS; NONDYSTROPHIC MYOTONIA; PARESTHESIA; PERIODIC PARALYSIS; POTASSIUM AGGRAVATED MYOTONIA; PRIORITY JOURNAL; RARE DISEASE; RASH; SIDE EFFECT; SYMPTOM; TASTE DISORDER; THOMSEN DISEASE; TREMOR; VISUAL IMPAIRMENT;

EID: 33947531150     PISSN: 19337213     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurt.2007.01.012     Document Type: Article

References (48)

1. Hudson A.J., Ebers G.C., and Bulman D.E. The skeletal muscle sodium and chloride channel diseases. Brain 118 (1995) 547-563
2. Preston D.C., and Shapiro B.E. Electromyography and neuromuscular disorders (1998), Butterworth-Heinemann, Boston
3. Streib E.W. AAEE minimonograph #27: Differential diagnosis of myotonic syndromes. Muscle Nerve 10 (1987) 603-615
4. Kimura J. Electrodiagnosis in diseases of nerve and muscle: principles and practice. 2nd ed. (1989), Davis, Philadelphia
5. Moxley RT 3rd. Approach to the evaluation of myotonia [oral presentation]. Presented at the 55th Annual Meeting, American Academy of Neurology; March 29-April 5, 2004; Honolulu, HI.
6. Dumitru D., and Amato A.A. Introduction to myopathies and muscle tissue's reaction to injury. In: Dumitru D., Amato A.A., and Zwarts M.J. (Eds). Electrodiagnostic medicine. 2nd ed. (2002), Hanley & Belfus, Philadelphia 1229-1264
7. Amato A.A., and Dumitru D. Hereditary myopathies. In: Dumitru D., Amato A.A., and Zwarts M.J. (Eds). Electrodiagnostic medicine. 2nd ed. (2002), Hanley & Belfus, Philadelphia 1265-1370
8. Moxley R.T., and Tawil R. Channelopathies: myotonic disorders and periodic paralysis. In: Swaiman K.F., Ashwal S., and Ferriero D.M. (Eds). Pediatric neurology: principles and practice. 4th ed. (2006), Mosby, Philadelphia 2085-2109
9. Rudel R., and Lehmann-Horn F. Paramyotonia, potassium-aggravated myotonias and periodic paralyses. 37th ENMC International Workshop, Naarden, The Netherlands, 8-10 December 1995. Neuromuscul Disord 7 (1997) 127-132
10. Russell S.H., and Hirsch N.P. Anaesthesia and myotonia. Br J Anaesth 72 (1994) 210-216
11. Ricker K., Rudel R., Lehmann-Horn F., and Kuther G. Muscle stiffness and electrical activity in paramyotonia congenita. Muscle Nerve 9 (1986) 299-305
12. Ricker K., Haass A., Rudel R., Bohlen R., and Mertens H.G. Successful treatment of paramyotonia congenita (Eulenburg): muscle stiffness and weakness prevented by tocainide. J Neurol Neurosurg Psychiatry 43 (1980) 268-271
13. Moxley III R.T., Ricker K., Kingston W.J., and Bohlen R. Potassium uptake in muscle during paramyotonic weakness. Neurology 39 (1989) 952-955
14. Gutmann L., and Phillips II L.H. Myotonia congenita. Semin Neurol 11 (1991) 244-248
15. Davies N.P., and Hanna M.G. Neurological channelopathies: diagnosis and therapy in the new millennium. Ann Med 31 (1999) 406-420
16. Shapiro B., and Ruff R. Disorders of skeletal muscle membrane excitability: myotonia congenita, paramyotonia congenita, periodic paralysis, and related disorders. In: Katirji B., Kaminski H.J., Preston D.C., Ruff R.L., and Shapiro B.E. (Eds). Neuromuscular disorders in clinical practice (2002), Butterworth-Heinemann, Boston 987-1020
17. Colding-Jørgensen E. Phenotypic variability in myotonia congenita. Muscle Nerve 32 (2005) 19-34
18. Becker PE, Knussmann R, Kuhn E, contributors; Passarge MF, translator. Myotonia congenita and syndromes associated with myotonia. Topics in Human Genetics 3. Stuttgart: Georg Thieme; 1977:1-178.
19. Lacomis D., Gonzales J.T., and Giuliani M.J. Fluctuating clinical myotonia and weakness from Thomsen's disease occurring only during pregnancies. Clin Neurol Neurosurg 101 (1999) 133-136
20. Lehmann-Horn F., Mailander V., Heine R., and George A.L. Myotonia levior is a chloride channel disorder. Hum Mol Genet 4 (1995) 1397-1402
21. Wagner S., Deymeer F., Kurz L.L., et al. The dominant chloride channel mutant G200R causing fluctuating myotonia: clinical findings, electrophysiology, and channel pathology. Muscle Nerve 21 (1998) 1122-1128
22. Lehmann-Horn F., and Rudel R. Hereditary nondystrophic myotonias and periodic paralyses. Curr Opin Neurol 8 (1995) 402-410
23. Duffield M., Rychkov G., Bretag A., and Roberts M. Involvement of helices at the dimer interface in ClC-1 common gating. J Gen Physiol 121 (2003) 149-161
24. Brooke M.H. Disorders of skeletal muscle. In: Bradley W.G., Daroff R.B., Fenichel G.M., and Marsden C.D. (Eds). Neurology in clinical practice. 3rd ed. (2003), Butterworth-Heinemann, Boston 2187-2235
25. Kwiecinski H., Ryniewicz B., and Ostrzycki A. Treatment of myotonia with antiarrhythmic drugs. Acta Neurol Scand 86 (1992) 371-375
26. Streib E.W. Paramyotonia congenita. Semin Neurol 11 (1991) 249-257
27. Eulenburg A. Über eine familiäre, durch 6 Generationen verfolgbare Form kongenitaler Paramyotonie. Neurol Zentralbl 5 (1886) 265-272
28. Surtees R. Inherited ion channel disorders. Eur J Pediatr 159 Suppl 3 (2000) S199-S203
29. Rudel R., Ricker K., and Lehmann-Horn F. Genotype-phenotype correlations in human skeletal muscle sodium channel diseases. Arch Neurol 50 (1993) 1241-1248
30. Ptacek L.J., Johnson K.J., and Griggs R.C. Genetics and physiology of the myotonic muscle disorders. N Engl J Med 328 (1993) 482-489
31. Brungger U., and Kaeser H.E. Paramyotonia congenita without cold paralysis and myotonia levior: a genetic and clinical study. Eur Neurol 15 (1977) 2-4
32. Ricker K., Lehmann-Horn F., and Moxley III R.T. Myotonia fluctuans. Arch Neurol 47 (1990) 268-272
33. Ricker K., Moxley III R.T., Heine R., and Lehmann-Horn F. Myotonia fluctuans: a third type of muscle sodium channel disease. Arch Neurol 51 (1994) 1095-1102
34. Colding-Jørgensen E., Duno M., and Vissing J. Autosomal dominant monosymptomatic myotonia permanens. Neurology 67 (2006) 153-155
35. Trudell R.G., Kaiser K.K., and Griggs R.C. Acetazolamide-responsive myotonia congenita. Neurology 37 (1987) 488-491
36. Ptacek L.J., Tawil R., Griggs R.C., Storvick D., and Leppert M. Linkage of atypical myotonia congenita to a sodium channel locus. Neurology 42 (1992) 431-433
37. Hanna M.G., Stewart J., Schapira A.H., Wood N.W., Morgan-Hughes J.A., and Murray N.M. Salbutamol treatment in a patient with hyperkalaemic periodic paralysis due to a mutation in the skeletal muscle sodium channel gene (SCN4A). J Neurol Neurosurg Psychiatry 65 (1998) 248-250
38. Tawil R., McDermott M.P., Brown Jr. R., et al., Working Group on Periodic Paralysis. Randomized trials of dichlorphenamide in the periodic paralyses. Ann Neurol 47 (2000) 46-53
39. Streib E.W. Paramyotonia congenita: successful treatment with tocainide; clinical and electrophysiologic findings in seven patients. Muscle Nerve 10 (1987) 155-162
40. Sansone V., Links T., Meola G., Rose M.R., and Cochrane Neuromuscular Disease Group. Treatment for periodic paralysis. (Protocol.). Cochrane Database Syst Rev 3 (2004) CD005045 (updated 2006;2)
41. Barchi R.L. Myotonia: an evaluation of the chloride hypothesis. Arch Neurol 32 (1975) 175-180
42. Kennedy F., and Wolf A. Experiments with quinine and prostigmine in the treatment of myotonia and myaesthenia. Arch Neurol Psychiatry 37 (1937) 68-74
43. Berardinelli A., Gorni K., and Orcesi S. Response to carbamazepine of recessive-type myotonia congenita. Muscle Nerve 23 (2000) 138-139
44. Gerst J.W., Brumback R.A., and Staton R.D. Lithium-induced improvement of myotonia. J Neurol Neurosurg Psychiatry 47 (1984) 1044-1046
45. Brown Jr. R.H. Ion channel mutations in periodic paralysis and related myotonic diseases. Ann N Y Acad Sci 707 (1993) 305-316
46. Ptacek L.J., Tawil R., Griggs R.C., et al. Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis. Neurology 44 (1994) 1500-1503
47. Fournier E., Arzel M., Sternberg D., et al. Electromyography guides toward subgroups of mutations in muscle channelopathies. Ann Neurol 56 (2004) 650-661
48. Rosenfeld J., Sloan-Brown K., and George Jr. A.L. A novel muscle sodium channel mutation causes painful congenital myotonia. Ann Neurol 42 (1997) 811-814